Therefore, by assessing the mitochondria-derived factors mediating the cell death process we successfully demonstrated that inhibition of uPAR and MMP-9 decreased the expression of Bcl-2 and Bcl-xL, activated Bid cleavage, and enhanced Bak expression in medulloblastoma cells. The gene discussed is BCL2; the disease is medulloblastoma.